Atlas Trials

Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study

Clinical trial NCT02620618 · COMPLETED

Trial details

NCT number
NCT02620618
Sponsor
Cairo University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Behçet's DiseaseUveitis
Start date
2013-01-01
Primary completion
2014-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.